ArticleSurgery today2020

Clinical outcomes of radical gastrectomy following trastuzumab-based chemotherapy for stage IV HER2-positive gastric or gastroesophageal junction cancer.

Ryo Takahashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.